The Role of MET in Melanoma and Melanocytic Lesions

Medicine and Dentistry

• Development 100%
• Lesion 100%
• Nodular Melanoma 100%
• Neoplasm 66%
• Tumor Progression 66%
• Targeted Therapy 66%
• Protein Tyrosine Kinase 66%
• Microenvironment 33%
• Biological Marker 33%
• Assessment 33%
• Precursor 33%
• Signal Transduction 33%
• Inpatient 33%
• Cancer 33%
• Incidence 33%
• Metastatic Carcinoma 33%
• Cause of Death 33%
• Melanocyte 33%
• Scatter Factor 33%
• Tumor Resistance 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Melanoma 100%
• Neoplasm 66%
• Tumor Growth 66%
• Protein Tyrosine Kinase 66%
• Biological Marker 33%
• Metastasis 33%
• Incidence 33%
• Cause of Death 33%
• Scatter Factor 33%
• Tumor Resistance 33%

Biochemistry, Genetics and Molecular Biology

• Development 100%
• Receptor Tyrosine Kinase 66%
• Tumor Progression 66%
• Sample 33%
• Comprehension 33%
• Signal Transduction 33%
• Incidence 33%
• Gene Mutation 33%
• Precursor 33%
• Melanocyte 33%
• Hepatocyte Growth Factor 33%